Last reviewed 2026-05-22 · How we verify

OXYTETRACYCLINE

FDA-approved approved Small molecule ✓ Verified May 2026 Quality 5/100

OXYTETRACYCLINE is a drug. It is currently FDA-approved (first approved 1964).

Oxytetracycline is a small molecule that inhibits the bacterial 70S ribosome, classified as an inhibitor. It is used to treat various conditions, including periodontitis, periodontal diseases, acne, boils, and osteomyelitis, often in combination with other treatments such as scaling and root planing, metronidazole, or amoxicillin.

At a glance

Generic name	OXYTETRACYCLINE
Modality	Small molecule
Phase	FDA-approved
First approval	1964

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery (NA)
Patients Response to Early Switch To Oral:Osteomyelitis Study (EARLY_PHASE1)
Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM (PHASE4)
Combination Therapy of Anthracyclines for Children With Nephroblastoma (PHASE4)
Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy (PHASE2, PHASE3)
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy (PHASE1, PHASE2)
Low Dose Doxycycline in the Treatment of Corneal Burn (PHASE2, PHASE3)
Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

OXYTETRACYCLINE CI brief — competitive landscape report
OXYTETRACYCLINE updates RSS · CI watch RSS

Frequently asked questions about OXYTETRACYCLINE

What is OXYTETRACYCLINE?

OXYTETRACYCLINE is a Small molecule drug.

When was OXYTETRACYCLINE approved?

OXYTETRACYCLINE was first approved on 1964.

What development phase is OXYTETRACYCLINE in?

OXYTETRACYCLINE is FDA-approved (marketed).

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing